Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience
/in Brain Tumors in Children, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2020-05-19 / Medicines (Basel) 2020 May;7(5)Feasibility of dendritic cell-based vaccine against glioblastoma by using cytoplasmic transduction peptide (CTP)-fused protein antigens combined with anti-PD1
/in Dendritic Cells, Glioblastoma, International Publications /von 2020-05-13 / Hum Vaccin Immunother 2020 May;:1-9Ex vivo pulsed dendritic cell vaccination against cancer
/in Dendritic Cells, International Publications /von 2020-05-04 / Acta Pharmacol Sin 2020 Jul;41(7):959-969Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2020-04-22 / Curr. Opin. Biotechnol. 2020 Apr;65:190-196Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2020-04-21 / J Transl Med 2020 04;18(1):176Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment
/in Dendritic Cells, International Publications /von 2020-04-07 / Clin Transl Oncol 2020 Apr;Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103 conventional dendritic cells
/in Dendritic Cells, International Publications /von 2020-04-01 / J Immunother Cancer 2020 Apr;8(1)Dendritic cell therapy in cancer treatment; the state-of-the-art
/in Dendritic Cells, International Publications /von 2020-03-20 / Life Sci. 2020 Aug;254:117580Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2020-03-16 / Cancer Cell 2020 03;37(3):289-307.e9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de